

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 5.24735644 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.08894639 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.89076913 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 4.73308540 |
| 5 | dopamine transport (GO:0015872) | 4.69780235 |
| 6 | regulation of female receptivity (GO:0045924) | 4.63961042 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.56839538 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.47708939 |
| 9 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.44042178 |
| 10 | adenosine receptor signaling pathway (GO:0001973) | 4.41228773 |
| 11 | monoamine transport (GO:0015844) | 4.41098778 |
| 12 | glutamate secretion (GO:0014047) | 4.34161552 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 4.32587896 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.08725591 |
| 15 | negative regulation of heart rate (GO:0010459) | 4.05223698 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.97294884 |
| 17 | female mating behavior (GO:0060180) | 3.96886713 |
| 18 | regulation of dopamine metabolic process (GO:0042053) | 3.93749019 |
| 19 | regulation of catecholamine metabolic process (GO:0042069) | 3.93749019 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.79924746 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 3.79190942 |
| 22 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.61628477 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 3.58629692 |
| 24 | regulation of platelet aggregation (GO:0090330) | 3.57314419 |
| 25 | positive regulation of mast cell activation (GO:0033005) | 3.56841257 |
| 26 | catecholamine transport (GO:0051937) | 3.50987899 |
| 27 | regulation of sensory perception of pain (GO:0051930) | 3.43797881 |
| 28 | regulation of sensory perception (GO:0051931) | 3.43797881 |
| 29 | dopamine biosynthetic process (GO:0042416) | 3.39182585 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.37435317 |
| 31 | vesicle docking involved in exocytosis (GO:0006904) | 3.35385431 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.34623132 |
| 33 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.28307033 |
| 34 | regulation of norepinephrine secretion (GO:0014061) | 3.27957835 |
| 35 | negative regulation of heart contraction (GO:0045822) | 3.27453964 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.26588720 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.25498381 |
| 38 | regulation of penile erection (GO:0060405) | 3.24306835 |
| 39 | synaptic vesicle endocytosis (GO:0048488) | 3.21167013 |
| 40 | negative regulation of response to food (GO:0032096) | 3.18699034 |
| 41 | negative regulation of appetite (GO:0032099) | 3.18699034 |
| 42 | negative regulation of norepinephrine secretion (GO:0010700) | 3.18613939 |
| 43 | negative regulation of stress fiber assembly (GO:0051497) | 3.15439853 |
| 44 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.12939484 |
| 45 | megakaryocyte development (GO:0035855) | 3.12194625 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.08213322 |
| 47 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.07930130 |
| 48 | relaxation of smooth muscle (GO:0044557) | 3.07295227 |
| 49 | sleep (GO:0030431) | 3.06807298 |
| 50 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.06327851 |
| 51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05401612 |
| 52 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.04974913 |
| 53 | neurotransmitter transport (GO:0006836) | 3.04797973 |
| 54 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04156989 |
| 55 | vesicle docking (GO:0048278) | 3.03965289 |
| 56 | neurotransmitter uptake (GO:0001504) | 3.03178825 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95779499 |
| 58 | purinergic receptor signaling pathway (GO:0035587) | 2.95442335 |
| 59 | blood coagulation, intrinsic pathway (GO:0007597) | 2.92715628 |
| 60 | regulation of platelet activation (GO:0010543) | 2.92606399 |
| 61 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.91807698 |
| 62 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.91212793 |
| 63 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.90853882 |
| 64 | positive regulation of mast cell degranulation (GO:0043306) | 2.89650309 |
| 65 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89650309 |
| 66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.86782302 |
| 67 | glutamate receptor signaling pathway (GO:0007215) | 2.86197148 |
| 68 | regulation of neurotransmitter levels (GO:0001505) | 2.83413373 |
| 69 | cerebellar granule cell differentiation (GO:0021707) | 2.83303098 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.82045765 |
| 71 | positive regulation of neurotransmitter transport (GO:0051590) | 2.81844253 |
| 72 | L-amino acid import (GO:0043092) | 2.80800256 |
| 73 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.80025750 |
| 74 | endothelium development (GO:0003158) | 2.78434374 |
| 75 | sodium ion export (GO:0071436) | 2.78232967 |
| 76 | platelet aggregation (GO:0070527) | 2.77579387 |
| 77 | membrane depolarization during action potential (GO:0086010) | 2.76765377 |
| 78 | regulation of exocytosis (GO:0017157) | 2.74962350 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 2.74778268 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.72648275 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.72648275 |
| 82 | exploration behavior (GO:0035640) | 2.72437357 |
| 83 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.72039765 |
| 84 | cyclooxygenase pathway (GO:0019371) | 2.70552384 |
| 85 | negative regulation of neurotransmitter transport (GO:0051589) | 2.70065713 |
| 86 | negative regulation of cation channel activity (GO:2001258) | 2.69673133 |
| 87 | regulation of glutamate secretion (GO:0014048) | 2.69202752 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 2.68510329 |
| 89 | response to cocaine (GO:0042220) | 2.68027873 |
| 90 | response to amphetamine (GO:0001975) | 2.66816423 |
| 91 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.65272997 |
| 92 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.65194048 |
| 93 | cellular potassium ion homeostasis (GO:0030007) | 2.60769989 |
| 94 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.60438485 |
| 95 | synaptic transmission, dopaminergic (GO:0001963) | 2.59045781 |
| 96 | long term synaptic depression (GO:0060292) | 2.58480504 |
| 97 | regulation of neurotransmitter secretion (GO:0046928) | 2.58433029 |
| 98 | response to gravity (GO:0009629) | 2.57349078 |
| 99 | neuronal action potential (GO:0019228) | 2.56710191 |
| 100 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55306710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.91526467 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.67529611 |
| 3 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.37793345 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19155387 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.02542365 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57937816 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.41112989 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.31698816 |
| 9 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.31110730 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25244743 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.16636622 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14871386 |
| 13 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13950527 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.13431539 |
| 15 | GATA1_19941826_ChIP-Seq_K562_Human | 2.07736756 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.01320875 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92506552 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.89882417 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89565121 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88740387 |
| 21 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.86781502 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.86030265 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84199288 |
| 24 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.84070327 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82817067 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.77206735 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71332597 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71125404 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69041373 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.68396207 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57636551 |
| 32 | GATA2_19941826_ChIP-Seq_K562_Human | 1.52706548 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50440001 |
| 34 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47221516 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46816685 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44297374 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.42417224 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41928711 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40797536 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39783369 |
| 41 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37627232 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37102938 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35182186 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32634364 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31524502 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29048254 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28550438 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25645495 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24189166 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16904922 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16322073 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15710407 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15165902 |
| 54 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11238484 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06843858 |
| 56 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06612312 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03833780 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03696461 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03408315 |
| 60 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.02307733 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01786487 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00094994 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00094994 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98885407 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98847867 |
| 66 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.97064521 |
| 67 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96712914 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94632109 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93725844 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93006390 |
| 71 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92277686 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91054067 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.90977919 |
| 74 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.89981253 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.87813772 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87729783 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.87089221 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86566098 |
| 79 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85803498 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84193840 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83948542 |
| 82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83370436 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82689399 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82426427 |
| 85 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.81870909 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81748345 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81267716 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80944757 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.80046578 |
| 90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.80046578 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79269305 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.79161011 |
| 93 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.78867503 |
| 94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.78318971 |
| 95 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76078356 |
| 96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.75801116 |
| 97 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75673117 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75646822 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.75279682 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.75155946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.12555889 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.98184253 |
| 3 | MP0003880_abnormal_central_pattern | 3.43771864 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.33814490 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.07091635 |
| 6 | MP0002736_abnormal_nociception_after | 3.04508826 |
| 7 | MP0008004_abnormal_stomach_pH | 2.81013019 |
| 8 | MP0009046_muscle_twitch | 2.77464608 |
| 9 | MP0005646_abnormal_pituitary_gland | 2.76652527 |
| 10 | MP0002064_seizures | 2.65723990 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.65171121 |
| 12 | MP0009745_abnormal_behavioral_response | 2.57682695 |
| 13 | MP0002733_abnormal_thermal_nociception | 2.54127196 |
| 14 | MP0002272_abnormal_nervous_system | 2.39532846 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.36133660 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.33311602 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.26219340 |
| 18 | MP0004270_analgesia | 2.16181128 |
| 19 | MP0001486_abnormal_startle_reflex | 2.15438415 |
| 20 | MP0001970_abnormal_pain_threshold | 2.12702079 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.04068472 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.02253852 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.98265916 |
| 24 | MP0003879_abnormal_hair_cell | 1.97586029 |
| 25 | MP0001905_abnormal_dopamine_level | 1.95962524 |
| 26 | MP0008872_abnormal_physiological_respon | 1.94436127 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 1.84314190 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.68263211 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.67362946 |
| 30 | MP0000230_abnormal_systemic_arterial | 1.67045134 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.64814395 |
| 32 | MP0008569_lethality_at_weaning | 1.63890452 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.63567493 |
| 34 | MP0003724_increased_susceptibility_to | 1.56432950 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.49413460 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.47063561 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.39640659 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.39340024 |
| 39 | MP0004147_increased_porphyrin_level | 1.38770429 |
| 40 | MP0003122_maternal_imprinting | 1.38725540 |
| 41 | MP0008874_decreased_physiological_sensi | 1.34598076 |
| 42 | MP0003329_amyloid_beta_deposits | 1.31856015 |
| 43 | MP0001984_abnormal_olfaction | 1.30507493 |
| 44 | MP0003638_abnormal_response/metabolism_ | 1.26110694 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.25771166 |
| 46 | MP0003633_abnormal_nervous_system | 1.23913415 |
| 47 | MP0005410_abnormal_fertilization | 1.23325004 |
| 48 | MP0004142_abnormal_muscle_tone | 1.21285652 |
| 49 | MP0002822_catalepsy | 1.16303071 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.15626493 |
| 51 | MP0003787_abnormal_imprinting | 1.15341595 |
| 52 | MP0003631_nervous_system_phenotype | 1.10914912 |
| 53 | MP0004811_abnormal_neuron_physiology | 1.08732456 |
| 54 | MP0004885_abnormal_endolymph | 1.04347552 |
| 55 | MP0008775_abnormal_heart_ventricle | 1.03953535 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.03551308 |
| 57 | MP0001188_hyperpigmentation | 1.02381873 |
| 58 | MP0004130_abnormal_muscle_cell | 1.01939726 |
| 59 | MP0004510_myositis | 0.99488665 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.97262439 |
| 61 | MP0004484_altered_response_of | 0.96965054 |
| 62 | MP0001835_abnormal_antigen_presentation | 0.96539991 |
| 63 | MP0005448_abnormal_energy_balance | 0.92922107 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 0.92215225 |
| 65 | MP0001664_abnormal_digestion | 0.92090372 |
| 66 | MP0005535_abnormal_body_temperature | 0.90752958 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.90248170 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.90248170 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.89366788 |
| 70 | MP0003690_abnormal_glial_cell | 0.88589575 |
| 71 | MP0002229_neurodegeneration | 0.88248774 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.87715047 |
| 73 | MP0004924_abnormal_behavior | 0.85817989 |
| 74 | MP0005386_behavior/neurological_phenoty | 0.85817989 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.84270921 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.83547511 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 0.83521083 |
| 78 | MP0004043_abnormal_pH_regulation | 0.81320699 |
| 79 | MP0004084_abnormal_cardiac_muscle | 0.80782500 |
| 80 | MP0000343_altered_response_to | 0.79151987 |
| 81 | MP0000604_amyloidosis | 0.77919512 |
| 82 | MP0000920_abnormal_myelination | 0.77865020 |
| 83 | MP0003303_peritoneal_inflammation | 0.76395088 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.75915850 |
| 85 | MP0005165_increased_susceptibility_to | 0.75446712 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.75341268 |
| 87 | MP0009278_abnormal_bone_marrow | 0.75173933 |
| 88 | MP0002882_abnormal_neuron_morphology | 0.74891638 |
| 89 | MP0003075_altered_response_to | 0.74424387 |
| 90 | MP0004085_abnormal_heartbeat | 0.73198319 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.72137536 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 0.71150131 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.70469262 |
| 94 | MP0003632_abnormal_nervous_system | 0.67405992 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.66353742 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.64020745 |
| 97 | MP0005000_abnormal_immune_tolerance | 0.62519801 |
| 98 | MP0001756_abnormal_urination | 0.59270345 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.58079725 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.58049188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.75222373 |
| 2 | Menorrhagia (HP:0000132) | 6.61299172 |
| 3 | Increased mean platelet volume (HP:0011877) | 6.14994363 |
| 4 | Petechiae (HP:0000967) | 5.86055137 |
| 5 | Abnormal platelet volume (HP:0011876) | 5.77732182 |
| 6 | Purpura (HP:0000979) | 5.28630768 |
| 7 | Focal motor seizures (HP:0011153) | 5.24337930 |
| 8 | Epistaxis (HP:0000421) | 5.22855283 |
| 9 | Myokymia (HP:0002411) | 4.86844041 |
| 10 | Limb dystonia (HP:0002451) | 4.59649857 |
| 11 | Gingival bleeding (HP:0000225) | 4.41519375 |
| 12 | Febrile seizures (HP:0002373) | 4.27362241 |
| 13 | Diplopia (HP:0000651) | 3.96913044 |
| 14 | Abnormality of binocular vision (HP:0011514) | 3.96913044 |
| 15 | Focal seizures (HP:0007359) | 3.65386862 |
| 16 | Polyphagia (HP:0002591) | 3.51524360 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.50630897 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.50630897 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.50398955 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.42351203 |
| 21 | Atonic seizures (HP:0010819) | 3.38753396 |
| 22 | Epileptic encephalopathy (HP:0200134) | 3.34820632 |
| 23 | Visual hallucinations (HP:0002367) | 3.29333438 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.26482121 |
| 25 | Delusions (HP:0000746) | 3.22884206 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.21886499 |
| 27 | Abnormality of the corticospinal tract (HP:0002492) | 3.07159017 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.02319071 |
| 29 | Spastic gait (HP:0002064) | 2.99509926 |
| 30 | Impaired platelet aggregation (HP:0003540) | 2.99097488 |
| 31 | Abnormal platelet function (HP:0011869) | 2.99097488 |
| 32 | Ankle clonus (HP:0011448) | 2.91711096 |
| 33 | Decreased central vision (HP:0007663) | 2.80518375 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80430688 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 2.72296010 |
| 36 | Poor eye contact (HP:0000817) | 2.70748374 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.68553668 |
| 38 | Poikilocytosis (HP:0004447) | 2.58045735 |
| 39 | Action tremor (HP:0002345) | 2.54398074 |
| 40 | Acanthocytosis (HP:0001927) | 2.49906258 |
| 41 | Mutism (HP:0002300) | 2.47688307 |
| 42 | Urinary urgency (HP:0000012) | 2.47435027 |
| 43 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.46759003 |
| 44 | Postural instability (HP:0002172) | 2.44585969 |
| 45 | Thyroid-stimulating hormone excess (HP:0002925) | 2.44510795 |
| 46 | Dialeptic seizures (HP:0011146) | 2.44189501 |
| 47 | Spontaneous abortion (HP:0005268) | 2.43051417 |
| 48 | Failure to thrive in infancy (HP:0001531) | 2.39855475 |
| 49 | Progressive cerebellar ataxia (HP:0002073) | 2.37488733 |
| 50 | Papilledema (HP:0001085) | 2.28910717 |
| 51 | Cerebral hypomyelination (HP:0006808) | 2.28809330 |
| 52 | Conjunctival telangiectasia (HP:0000524) | 2.27205872 |
| 53 | Abnormal pupillary function (HP:0007686) | 2.27072643 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.25608302 |
| 55 | Torticollis (HP:0000473) | 2.25589882 |
| 56 | Hemiplegia (HP:0002301) | 2.25576643 |
| 57 | Absence seizures (HP:0002121) | 2.22508037 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.22231998 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.18297698 |
| 60 | Paralysis (HP:0003470) | 2.18146031 |
| 61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15671706 |
| 62 | Dyschromatopsia (HP:0007641) | 2.14337428 |
| 63 | Focal dystonia (HP:0004373) | 2.13180702 |
| 64 | Impaired vibratory sensation (HP:0002495) | 2.12712510 |
| 65 | Craniofacial dystonia (HP:0012179) | 2.11669987 |
| 66 | Truncal ataxia (HP:0002078) | 2.07971262 |
| 67 | Bradykinesia (HP:0002067) | 2.06748232 |
| 68 | Hyperthyroidism (HP:0000836) | 2.03189940 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 2.02701740 |
| 70 | Agitation (HP:0000713) | 2.01723680 |
| 71 | Bruising susceptibility (HP:0000978) | 2.01418127 |
| 72 | Memory impairment (HP:0002354) | 2.00265386 |
| 73 | Cerebral inclusion bodies (HP:0100314) | 2.00048312 |
| 74 | Impaired social interactions (HP:0000735) | 1.99826388 |
| 75 | Abnormal social behavior (HP:0012433) | 1.99826388 |
| 76 | Termporal pattern (HP:0011008) | 1.96842003 |
| 77 | Insidious onset (HP:0003587) | 1.96842003 |
| 78 | Split foot (HP:0001839) | 1.94003999 |
| 79 | Scanning speech (HP:0002168) | 1.92460913 |
| 80 | Hemiparesis (HP:0001269) | 1.88394172 |
| 81 | Rigidity (HP:0002063) | 1.88045587 |
| 82 | Neurofibrillary tangles (HP:0002185) | 1.85239930 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 1.84191384 |
| 84 | Hypokinesia (HP:0002375) | 1.83868734 |
| 85 | Autoamputation (HP:0001218) | 1.83047417 |
| 86 | Clonus (HP:0002169) | 1.79337350 |
| 87 | Acute lymphatic leukemia (HP:0006721) | 1.78904185 |
| 88 | Status epilepticus (HP:0002133) | 1.74113401 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 1.73387448 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73376668 |
| 91 | Dyskinesia (HP:0100660) | 1.73330227 |
| 92 | Joint swelling (HP:0001386) | 1.71177344 |
| 93 | Stomatitis (HP:0010280) | 1.69259367 |
| 94 | Anxiety (HP:0000739) | 1.68254128 |
| 95 | Lower limb amyotrophy (HP:0007210) | 1.65657395 |
| 96 | Tetraplegia (HP:0002445) | 1.64029926 |
| 97 | Diminished movement (HP:0002374) | 1.60318808 |
| 98 | Episodic fever (HP:0001954) | 1.60294156 |
| 99 | Akinesia (HP:0002304) | 1.60178348 |
| 100 | Abnormal EKG (HP:0003115) | 1.58398627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DAPK2 | 3.88094772 |
| 2 | MST4 | 3.45817965 |
| 3 | RIPK4 | 3.36695159 |
| 4 | GRK7 | 3.14500926 |
| 5 | FES | 2.85954062 |
| 6 | EPHA4 | 2.85455383 |
| 7 | GRK5 | 2.67884317 |
| 8 | TAOK3 | 2.62725753 |
| 9 | NTRK3 | 2.10078342 |
| 10 | CAMKK2 | 2.05827805 |
| 11 | SIK2 | 2.02890903 |
| 12 | BMX | 1.99582364 |
| 13 | DAPK1 | 1.91884866 |
| 14 | TEC | 1.90071587 |
| 15 | CAMKK1 | 1.73392857 |
| 16 | MAP2K7 | 1.69177036 |
| 17 | BMPR2 | 1.67409354 |
| 18 | PAK6 | 1.63963464 |
| 19 | PTK2B | 1.63096683 |
| 20 | SYK | 1.62237998 |
| 21 | MINK1 | 1.59846438 |
| 22 | TNK2 | 1.55028172 |
| 23 | NTRK2 | 1.54295621 |
| 24 | MYLK | 1.53588697 |
| 25 | PLK2 | 1.49260633 |
| 26 | MARK1 | 1.47549035 |
| 27 | MAP3K12 | 1.46270769 |
| 28 | MAPK13 | 1.43359623 |
| 29 | BTK | 1.43249938 |
| 30 | PKN1 | 1.36194284 |
| 31 | CDK19 | 1.31009978 |
| 32 | DAPK3 | 1.28806568 |
| 33 | CAMK2B | 1.27653986 |
| 34 | CSF1R | 1.20745276 |
| 35 | ADRBK1 | 1.13289398 |
| 36 | CAMK1 | 1.09936227 |
| 37 | TLK1 | 1.08781665 |
| 38 | CAMK2A | 1.08320301 |
| 39 | HCK | 1.04257539 |
| 40 | PNCK | 1.04143271 |
| 41 | MAPKAPK5 | 1.02484093 |
| 42 | PHKG1 | 1.02356489 |
| 43 | PHKG2 | 1.02356489 |
| 44 | PRKD3 | 0.97445719 |
| 45 | FGR | 0.97439949 |
| 46 | EPHA3 | 0.95052593 |
| 47 | CDK5 | 0.91229387 |
| 48 | RET | 0.88748442 |
| 49 | PINK1 | 0.87883845 |
| 50 | CAMK2G | 0.86125636 |
| 51 | MARK2 | 0.85752441 |
| 52 | PAK3 | 0.85378294 |
| 53 | MAP3K4 | 0.84403233 |
| 54 | CCNB1 | 0.82319521 |
| 55 | UHMK1 | 0.82303863 |
| 56 | KIT | 0.81551625 |
| 57 | CAMK2D | 0.78619955 |
| 58 | CSNK1G2 | 0.77741721 |
| 59 | FER | 0.77717719 |
| 60 | PRKCG | 0.76375078 |
| 61 | ADRBK2 | 0.75534560 |
| 62 | GRK6 | 0.75514776 |
| 63 | MAPK12 | 0.73193018 |
| 64 | LYN | 0.72774488 |
| 65 | CSNK1G3 | 0.70922789 |
| 66 | MAP3K1 | 0.70013989 |
| 67 | ILK | 0.69872983 |
| 68 | MAP3K5 | 0.69720026 |
| 69 | CDK14 | 0.69348311 |
| 70 | MAP3K6 | 0.67846592 |
| 71 | ITK | 0.67565336 |
| 72 | PBK | 0.65138423 |
| 73 | MAP2K4 | 0.63178111 |
| 74 | IRAK1 | 0.61416427 |
| 75 | CDK15 | 0.58706201 |
| 76 | TXK | 0.57606248 |
| 77 | PDK1 | 0.57445946 |
| 78 | CDK18 | 0.57402657 |
| 79 | BRSK2 | 0.57282421 |
| 80 | DYRK1A | 0.57054087 |
| 81 | ERBB2 | 0.57019640 |
| 82 | NME1 | 0.55641676 |
| 83 | PIK3CG | 0.55093809 |
| 84 | MAPKAPK3 | 0.54911961 |
| 85 | PRKCA | 0.54054391 |
| 86 | ZAP70 | 0.52441195 |
| 87 | PAK1 | 0.50461540 |
| 88 | CDK11A | 0.50326112 |
| 89 | PRKACG | 0.50143812 |
| 90 | ARAF | 0.49470875 |
| 91 | JAK2 | 0.49045393 |
| 92 | FYN | 0.48673380 |
| 93 | OXSR1 | 0.47822811 |
| 94 | PRKD1 | 0.45200710 |
| 95 | SIK3 | 0.45045561 |
| 96 | TNIK | 0.41662611 |
| 97 | LMTK2 | 0.40176624 |
| 98 | MATK | 0.38512091 |
| 99 | PRKACA | 0.37961292 |
| 100 | MAPK10 | 0.34381368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.44643536 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.43486869 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 3.06453712 |
| 4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.69051860 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66629221 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.61374884 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53120365 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.53028354 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.43792243 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.33264661 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.29737502 |
| 12 | Cocaine addiction_Homo sapiens_hsa05030 | 2.22706346 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.17997861 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.94464655 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91970180 |
| 16 | * Olfactory transduction_Homo sapiens_hsa04740 | 1.85781613 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80662678 |
| 18 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.75431849 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73321225 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.68130018 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.64995464 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.60389197 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.59825713 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.55733275 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53502503 |
| 26 | Gap junction_Homo sapiens_hsa04540 | 1.51585601 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.50451136 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.49659496 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.45593033 |
| 30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44411948 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.33669138 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30467852 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.29939670 |
| 34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.28537618 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26303907 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.22668434 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12223563 |
| 38 | Alcoholism_Homo sapiens_hsa05034 | 1.11579643 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06456850 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05656288 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02750007 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01235235 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97428850 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97210263 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90568738 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89639859 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85718565 |
| 48 | Endocytosis_Homo sapiens_hsa04144 | 0.85560930 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85407577 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82833286 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81866469 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78470153 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76245503 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73195117 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72397080 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69222015 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68411841 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65545091 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64771156 |
| 60 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64308424 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62985130 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61475690 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60954184 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60511310 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60251302 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.58522973 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56705380 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.53322454 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53184567 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52993673 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51976264 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51847454 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51662203 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49953633 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48912183 |
| 76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48764593 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47931771 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47641200 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.46338466 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43208624 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43124319 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42888736 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.42571898 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.37993254 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.37890148 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37863096 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37565269 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34748486 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.34527063 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34381353 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31982492 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31909314 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31080865 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.30217537 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.29793321 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29756642 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29363681 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28667431 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.28553814 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26293390 |

